AGATHISHA
INSTITUTE OF STEMCELL AND
REGENERATIVE MEDICINE
Home/Clinical Care/Treatment Pathways
Every pathway has a stage at which we stop and reassess against objective measurements — not against how optimistic anyone is feeling.
Early to moderate osteoarthritis of the knee, hip or shoulder; cartilage defects; persistent post-injury joint pain.
Weight-bearing X-ray and MRI, functional scoring, and a walking-distance baseline we can measure against later.
Grade 4 joint space loss usually means surgery serves you better than biologics. We will say so.
Bone marrow or adipose harvest, GMP processing and intra-articular delivery under ultrasound guidance, in a single day.
Loading protocol supervised by physiotherapy. This phase matters at least as much as the injection.
Repeat functional scoring. If there is no measurable change, we say so and discuss alternatives rather than selling a second round.
3 moto first review
Chronic tendinopathy, partial tears, and post-surgical soft tissue healing that has plateaued.
Dynamic ultrasound to characterise the lesion, plus load testing to establish a functional baseline.
Full-thickness tears go to surgical review, not to biologics. Partial lesions proceed.
Autologous blood-derived preparation, processed to a standardised platelet concentration and delivered under ultrasound guidance.
Graded eccentric loading programme. Rest alone does not heal tendon; controlled load does.
Repeat ultrasound and load testing against your week-0 baseline.
Pathways C & D
Lower volume, more specialised, and usually run jointly with your referring surgeon.
Non-union and delayed-union fractures, critical-size defects and post-resection bone loss.
Defect volume and vascularity assessed jointly with the referring surgeon.
Matched to defect geometry and expected load-bearing demand.
Cell-seeded scaffold implanted, usually during a planned surgical episode.
Union assessed radiographically at 6, 12 and 24 weeks.
Chronic non-healing wounds, diabetic foot ulceration and hypertrophic scarring.
Perfusion, infection status and glycaemic control reviewed first — all three must be addressed before cells can help.
Untreated infection or critical ischaemia stops the pathway until resolved.
Applied topically or by peri-wound injection, with standard dressing care continuing throughout.
Planimetric wound area tracked weekly for twelve weeks.
Send your history and imaging and we will tell you which pathway fits — or whether none of them does.